1[1]Itu C. Matsui T, Wu T- S. Furukawa H. Isolation of 6,7-demethyle- nedesoxypodophyllotoxin from Hernandia ovigera. Chem. Pharm. Bull, 1992, 40:1318-21.
2[2]Yamaguchi H, Arimuto M, Yamamoto K, Numata A. Studies on the constituents of the seeds of Hernandia ovigera L.Yakugaku Zasshi, 1979, 99:674 - 7.
3[3]Yamaguchi H. Arimoto M. Tanoguchi M, Ishida T. Inoue M. studies on the constituents of the seeds of Hernandia ovigera L Ⅲ.Structures of two new lignans. Chem. Pharm.Bull, 1982, 30:3212- 8.
4[4]Tanoguchi M. Arimoto M, Saika H. Yamaguchi H. Studies on the constituents of the seeds of Hernandia ovigera L. Ⅵ.Isolationand structural determination of three lignans. Chem.Pharm. Bull, 1987, 35:4162-8.
5[5]Issell BF. The podophyllotoxin derivatives VP16- 213 and VM26.Cancer Chemother. Pharmacol, 1982, 7:73-80.
6[6]Konoshima T. Kozuka M Tokuda H. Nishino H, Iwashima A. Har una M et at. Studies on inhibitors of skin tumor promotion Ⅸ.Neolignans from Magnolia officinalis J. Nat Pod,1991, 54:816-22.
7[7]Takasaki M, Konoshima T, Yasuda 1. Hamano T. Tokuda H. Inhibi tory effects of shouseiryu- to on two- stage carcinogenesis. Ⅱ. An ti- tumor- promoting activities of lignans from Asiasarum hetero- tropoides var. mandshuricum. Biol.pharm. Bull, 1997, 20: 776-80.
8[8]Ito C, Itoigawa M, Furukawa H. Ichiishi E, Mukainaka T,Okuda M et al. Anti- tumor- promoting effects of phenylpropanoids on Epstein- Barr virus activation and two- stage mouse skin carcino- genesis. Cancer Letter, 1999, 142:49-54.
9[9]Ito C. Itoigawa M. Otsuka T. Tokuda H. Nishino H. Furukawa H. Constituents of Boronia pinnata. J. Nat. Prod. in press.
10[10]Murakami A, Ohigashi H. Koshimizu K. Anti-tumor promotion with food phytochemicals: A strategy for cancer chemoprevention. Biosci, Biotech. Biochem, 1996, 60: 1-8.
